期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

强化调脂大幅降低心血管事件研究进展 被引量：1

Advances in research of strongthening modifying lipid effect aimed for reducing greatly cardiovascular events
下载PDF
导出
摘要 动脉粥样硬化(AS)为心血管疾病致残致死最常见、最重要的病理改变,它是在高血压、吸烟、血脂异常、糖尿病等危险因素中的任何一种或多种因素损害动脉内皮功能的基础上形成的,其中血脂异常既是损害动脉内皮的危险因素,又是粥样硬化斑块的构成成分,是心血管事件发生发展的关键因素.
作者 徐成斌
机构地区 北京大学人民医院
出处 《临床药物治疗杂志》 2005年第3期5-10,共6页 Clinical Medication Journal
关键词 心血管事件 动脉粥样硬化(AS) 调脂 强化 动脉内皮功能 粥样硬化斑块 血脂异常 危险因素 心血管疾病 病理改变 构成成分 发生发展 高血压 糖尿病 损害
分类号 R544.1 [医药卫生—心血管疾病] R446.1 [医药卫生—诊断学]
  • 相关文献

参考文献18

  • 1[1]Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults( Adult Treatment Panel Ⅲ). JAMA,2001,285:2486～2249
  • 2[2]Grundy SM, Cleeman JI, Merz C. NB, et al. (NCEP Report). Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel Ⅲ Guidelines. Circulation,2004,110:227～239
  • 3杨万勇,王毅敏.糖尿病患者血脂和载脂蛋白关系的探讨[J].宁夏医学杂志,2001,23(3):136-137. 被引量：43
  • 4[4]Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high - risk individuals: a randomized placebo - controlled trial.Lancet,2002,360 (9326) :7～22
  • 5[5]MAAS Investigators: Effect of simvastatin on coronary atheroma: The Multicentre Anti- Atheroma Study (MAAS). Lancet, 1994,344,633～638
  • 6[6]Jukema JW, Bruschke AVG, van Boven AJ, et al. On behalf of the REGRESS Study Group: Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS ). Circulation, 1995,91: 2528～2540
  • 7[7]Post Coronary Artery Bypass Graft Trial Investigators: The effect of intensive lowering of low - density lipoprotein cholesterol levels and low - dose anticoagulation on obstructive changes in saphenous- vein coronary artery bypass grafts. N Engl J Med, 1997,336:153～162
  • 8[8]Schwartz GG, Olsson AG, Ezekowitz MD, et al. Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACLE ) Study Investigators. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndrome: the MIRACLE study: a randomized controlled trial. JAMA, 2001, 285 :1711～1718
  • 9[9]Pitt B, Waters D, Brown WV, et al. Aggressive lipid lowering compared with angioplasty in stable artery disease(AVERT). N Engl J Med, 1999,341:70～76
  • 10[11]Cannon CP, Braunwald E, McCabe CH, et al. Pravastatin or Atorvastatin Evaluation and Infection Therapy - Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes ( PROVEIT). N Engl J Med,2004,350:1495～1504

二级参考文献3

共引文献57

同被引文献11

引证文献1

二级引证文献2

临床药物治疗杂志
2005年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部